Article

Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance Analysis

2021-08-18

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> To counter the COVID-19 pandemic, mRNA vaccines, namely tozinameran and elasomeran, have been authorized in several countries. These next generation vaccines have shown high efficacy against COVID-19 and demonstrated a favorable safety profile. As widespread vaccinations efforts are taking place, incidents of myocarditis and pericarditis cases following vaccination have been r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 57bbdf38-6251-5914-a883-8e7c8ea2fe4f
DOI: 10.1101/2021.08.12.21261955

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cardiac Inflammation after COVID-19 mRNA Vaccines: A Global Pharmacovigilance AnalysisDOI 10.1101/2021.08.12.21261955Read

Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccinesSemantic proximity Read

Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease and Platform-Inherent ChallengesSemantic proximity Read

COVID-19 mRNA Vaccines: From Inflammation to HyperinflammationSemantic proximity Read

Case Report: Acute myocardial infarction with acute left ventricular failure and acute renal damage following mRNA-1273 vaccination: Possible adverse effect of COVID-19 vaccination?Semantic proximity Read

The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying MechanismSemantic proximity Read

Vaccines Associated Cardiac Adverse Events, including SARS-CoV-2 Myocarditis, Elevated Histamine Etiology HypothesisSemantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

Can sarcopenia index serve as a predictor of myocarditis from mRNA based COVID-19 vaccine, insights from clustered cases and potential involvement of micro-RNAs in its pathogenesis.Semantic proximity Read

Incidence and management of the main adverse effects reported after COVID-19 vaccinationSemantic proximity Read

Quality and methodological heterogeneity of COVID-19 vaccine safety studies focusing on the myocarditis safety signal: A systematic review, meta-analysis and meta-regressionSemantic proximity Read

Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccinationSemantic proximity Read

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read